| scholarly article | Q13442814 |
| P2093 | author name string | Seyed Mahmoud Latifi | |
| Babak Payami | |||
| Isa Khaheshi | |||
| Habib Haybar | |||
| Ahmadreza Assareh | |||
| Yasaman Ghotbi | |||
| P2860 | cites work | Pentraxins: structure, function, and role in inflammation | Q28676262 |
| Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation | Q29147380 | ||
| Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials | Q31056275 | ||
| Prevalence of coronary artery disease risk factors in Iran: a population based survey | Q33304394 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies | Q34154838 | ||
| Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response | Q34159058 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes | Q34751855 | ||
| Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis | Q35133148 | ||
| The impact of early regular cardiac rehabilitation program on myocardial function after acute myocardial infarction | Q35843326 | ||
| The long pentraxin PTX3 in vascular pathology | Q36615475 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. | Q37775325 | ||
| Pentraxins and atherosclerosis: the role of PTX3. | Q37827889 | ||
| Pentraxin 3 Is Highly Specific for Predicting Anatomical Complexity of Coronary Artery Stenosis as Determined by the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score. | Q42761220 | ||
| Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise. | Q42966416 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Reduction in C-reactive protein through cardiac rehabilitation and exercise training | Q44803688 | ||
| Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation | Q46662705 | ||
| Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris | Q46927817 | ||
| The Impacts of Cardiac Rehabilitation Program on Exercise Capacity, Quality of Life, and Functional Status of Coronary Artery Disease Patients with Left Ventricular Dysfunction | Q48076003 | ||
| Pentraxin-3 predicts functional recovery and 1-year major adverse cardiovascular events after rehabilitation of cardiac surgery patients | Q48758001 | ||
| Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases | Q48901808 | ||
| Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease. | Q51266681 | ||
| Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. | Q53502969 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris | Q56942761 | ||
| The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community | Q61454238 | ||
| Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial | Q73669965 | ||
| Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women | Q84563126 | ||
| Global burden of cardiovascular disease | Q85848803 | ||
| P433 | issue | 2 | |
| P921 | main subject | coronary artery bypass surgery | Q186020 |
| P304 | page(s) | 59-65 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Cardiology research | Q27723945 |
| P1476 | title | Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients | |
| P478 | volume | 7 |
Search more.